From the House Energy & Commerce Committee Republicans press office:


WASHINGTON, DC – House Speaker Nancy Pelosi’s closely guarded, secretly negotiated, completely partisan bill has finally been unveiled. In response, all 24 Republicans, including Whip Scalise, on the House Energy and Commerce Committee criticized her partisan process to what has typically been, and should continue to be, a collaborative and bipartisan effort to bring down drug prices for the American people:

“We can solve this problem; we have solutions at the ready. We have advanced numerous policies aimed at lowering the costs of prescription drugs. In fact, in May, the House Energy and Commerce Committee passed bipartisan legislation to bring down prescription drug prices only to have Speaker Nancy Pelosi put politics over progress. Now Speaker Pelosi is back at it—pushing a socialist proposal to appease her most extreme members. It does not have to be this way; there are bipartisan solutions to bring down prices for patients and create real transparency and accountability for this system,” said all 24 Republicans on the Energy and Commerce Committee.

Republican Energy and Commerce Members include: Reps. Greg Walden (R-OR), E&C Republican Leader; Fred Upton (R-MI); John Shimkus (R-IL); Michael Burgess (R-TX); Steve Scalise (R-LA); Bob Latta (R-OH); Cathy McMorris Rodgers (R-WA); Brett Guthrie (R-KY); Pete Olson (R-TX); David McKinley (R-WV); Adam Kinzinger (R-IL); Morgan Griffith (R-VA); Gus Bilirakis (R-FL); Bill Johnson (R-OH); Billy Long (R-MO); Larry Bucshon (R-IN); Bill Flores (R-TX); Susan Brooks (R-IN); Markwayne Mullin (R-OK); Richard Hudson (R-NC); Tim Walberg (R-MI); Buddy Carter (R-GA); Jeff Duncan (R-SC); and Greg Gianforte (R-MT).

In the past, with a bipartisan and inclusive process, Republicans have worked with Democrats to push for legislation that promotes competition, lowers out-of-pocket costs for consumers, and establishes transparency and accountability in drug pricing. Here’s a recap of those bipartisan successes:
Last Congress and this Congress, the House has had several bills signed into law that have resulted in cost savings to consumers:
This Congress, the House has also passed several bills that are awaiting a vote in the Senate:
This Congress, the Energy & Commerce Committee has referred several bipartisan billsthat are awaiting a House floor vote:
In addition to legislation above, Republicans have acted in previous Congresses to reduce drug prices by encouraging innovation and increasing competition.
These policies prove that Congress can get real results to make prescription drugs more affordable. Last year FDA approved a record number of generic drugs – 971 in total, the most in history – driving competition and giving consumers more choices, notably including the first generic version of the EpiPen.
And there’s still more that could be done. Republicans continue to be open to working in a bipartisan way to lower drug costs.